Jia Zhu1, David T Breault1. 1. Department of Pediatrics, Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
Abstract
BACKGROUND: X-linked adrenoleukodystrophy (ALD) affects up to 25% of boys diagnosed with adrenal insufficiency in childhood. Because early identification of these individuals can be lifesaving, all boys with new-onset primary adrenal insufficiency should be tested for ALD with a plasma very long-chain fatty acid (VLCFA) level. While plasma VLCFA is a diagnostic test with high sensitivity and specificity, false-positive results have been reported in individuals on a ketogenic diet. CASE PRESENTATION: We present a case of an 11-year-old boy with new-onset primary adrenal insufficiency due to autoimmune adrenalitis who was initially found to have elevated VLCFA levels, suggestive of ALD, that normalized on repeat testing. CONCLUSIONS: As advances in gene therapy and newborn screening for ALD expand, VLCFA testing may increase, and clinicians should be aware that testing during the initial presentation of primary adrenal insufficiency may lead to false-positive results and associated psychosocial distress.
BACKGROUND: X-linked adrenoleukodystrophy (ALD) affects up to 25% of boys diagnosed with adrenal insufficiency in childhood. Because early identification of these individuals can be lifesaving, all boys with new-onset primary adrenal insufficiency should be tested for ALD with a plasma very long-chain fatty acid (VLCFA) level. While plasma VLCFA is a diagnostic test with high sensitivity and specificity, false-positive results have been reported in individuals on a ketogenic diet. CASE PRESENTATION: We present a case of an 11-year-old boy with new-onset primary adrenal insufficiency due to autoimmune adrenalitis who was initially found to have elevated VLCFA levels, suggestive of ALD, that normalized on repeat testing. CONCLUSIONS: As advances in gene therapy and newborn screening for ALD expand, VLCFA testing may increase, and clinicians should be aware that testing during the initial presentation of primary adrenal insufficiency may lead to false-positive results and associated psychosocial distress.
Authors: B H Vogel; S E Bradley; D J Adams; K D'Aco; R W Erbe; C Fong; A Iglesias; D Kronn; P Levy; M Morrissey; J Orsini; P Parton; J Pellegrino; C A Saavedra-Matiz; N Shur; M Wasserstein; G V Raymond; M Caggana Journal: Mol Genet Metab Date: 2015-02-12 Impact factor: 4.797
Authors: Jia Zhu; Florian Eichler; Alessandra Biffi; Christine N Duncan; David A Williams; Joseph A Majzoub Journal: Endocr Rev Date: 2020-08-01 Impact factor: 19.871
Authors: Florian Eichler; Christine Duncan; Patricia L Musolino; Paul J Orchard; Satiro De Oliveira; Adrian J Thrasher; Myriam Armant; Colleen Dansereau; Troy C Lund; Weston P Miller; Gerald V Raymond; Raman Sankar; Ami J Shah; Caroline Sevin; H Bobby Gaspar; Paul Gissen; Hernan Amartino; Drago Bratkovic; Nicholas J C Smith; Asif M Paker; Esther Shamir; Tara O'Meara; David Davidson; Patrick Aubourg; David A Williams Journal: N Engl J Med Date: 2017-10-04 Impact factor: 91.245
Authors: Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen Journal: Nat Rev Endocrinol Date: 2016-06-17 Impact factor: 43.330
Authors: Katie Wiens; Susan A Berry; Hyoung Choi; Amy Gaviglio; Ashish Gupta; Amy Hietala; Daniel Kenney-Jung; Troy Lund; Weston Miller; Elizabeth I Pierpont; Gerald Raymond; Holly Winslow; Heather A Zierhut; Paul J Orchard Journal: Am J Med Genet A Date: 2019-05-10 Impact factor: 2.802
Authors: Stacey Lee; Kristin Clinard; Sarah P Young; Catherine W Rehder; Zheng Fan; Ali S Calikoglu; Deeksha S Bali; Donald B Bailey; Lisa M Gehtland; David S Millington; Hari S Patel; Sara E Beckloff; Scott J Zimmerman; Cynthia M Powell; Jennifer L Taylor Journal: JAMA Netw Open Date: 2020-01-03